BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20405515)

  • 1. von Willebrand factor and thrombin activation in children with newly diagnosed acute lymphoblastic leukemia: an impact of peripheral blasts.
    Athale U; Moghrabi A; Nayiager T; Delva YL; Thabane L; Chan AK
    Pediatr Blood Cancer; 2010 Jul; 54(7):963-9. PubMed ID: 20405515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia.
    Giordano P; Molinari AC; Del Vecchio GC; Saracco P; Russo G; Altomare M; Perutelli P; Crescenzio N; Santoro N; Marchetti M; De Mattia D; Falanga A
    Am J Hematol; 2010 May; 85(5):325-30. PubMed ID: 20425794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Willebrand Factor and Factor VIII levels in Egyptian children with newly diagnosed acute lymphoblastic leukemia in relation to peripheral blast cells and steroid therapy.
    El Sherif NH; Narouz MF; Elkerdany TA; El Habashy SA
    J Pediatr Hematol Oncol; 2014 Oct; 36(7):518-23. PubMed ID: 25105915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
    Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
    Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors.
    LeBlanc R; Roy J; Demers C; Vu L; Cantin G
    Bone Marrow Transplant; 1999 May; 23(10):991-6. PubMed ID: 10373063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
    Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R
    Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between hemostatic factors and the platelet index in patients with ischemic heart disease.
    Ihara A; Kawamoto T; Matsumoto K; Shouno S; Morimoto T; Noma Y
    Pathophysiol Haemost Thromb; 2006; 35(5):388-91. PubMed ID: 17230041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Markers of thrombin generation in kidney failure of children with epidemic hemolytic uremic syndrome].
    Marta RF; Florentin L; Díaz M; Indaburu P; Sánchez Avalos JC; Molinas FC
    Medicina (B Aires); 1998; 58(1):8-12. PubMed ID: 9674202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to-severe aortic stenosis.
    Natorska J; Bykowska K; Hlawaty M; Marek G; Sadowski J; Undas A
    Heart; 2011 Dec; 97(24):2023-8. PubMed ID: 21561895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between hemostatic markers and platelet indices in patients with aortic aneurysm.
    Ihara A; Matsumoto K; Kawamoto T; Shouno S; Kawamoto J; Katayama A; Yoshitatsu M; Izutani H
    Pathophysiol Haemost Thromb; 2006; 35(6):451-6. PubMed ID: 17565239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease.
    Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
    Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):171-6. PubMed ID: 15649725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral anticoagulant therapy on thrombospondin-1 and von Willebrand factor in patients with stable heart failure.
    Vila V; Sales VM; Almenar L; Lázaro IS; Villa P; Reganon E
    Thromb Res; 2008; 121(5):611-5. PubMed ID: 17692904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden.
    Eichinger S; Weltermann A; Philipp K; Hafner E; Kaider A; Kittl EM; Brenner B; Mannhalter C; Lechner K; Kyrle PA
    Thromb Haemost; 1999 Oct; 82(4):1232-6. PubMed ID: 10544904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cell activation and blood coagulation in critically ill patients with lung injury.
    Wenzel C; Kofler J; Locker GJ; Laczika K; Quehenberger P; Frass M; Knöbl P
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):853-8. PubMed ID: 12503477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase.
    Oner AF; Gürgey A; Kirazli S; Okur H; Tunç B
    Leuk Lymphoma; 1999 Apr; 33(3-4):361-4. PubMed ID: 10221516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia.
    Mitchell LG; Halton JM; Vegh PA; Barr RD; Venneri T; Pai KM; Andrew ME
    Am J Pediatr Hematol Oncol; 1994 May; 16(2):120-6. PubMed ID: 8166364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
    Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
    Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
    Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.